SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Changes in goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
Sep. 30, 2021	Sep. 30, 2020
Goodwill
Goodwill, beginning balance	$ 4,368	$ 3,617
Goodwill, ending balance	51,927	4,368
Pre-Clinical Research Services, Inc.
Goodwill
Acquisition during the period		$ 751
HistoTox Labs
Goodwill
Acquisition during the period	9,129
Bolder BioPATH
Goodwill
Acquisition during the period	36,223
Gateway Pharmacology Laboratories LLC
Goodwill
Acquisition during the period	$ 2,207

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant